India's cheap weight-loss drugs could reshape global obesity fight

3 hours ago 2
With India’s semaglutide patent expiring on 20 March, about 50 branded generics are expected to enter the market.
Read Entire Article
All trademarks and copyrights on this page are owned by their respective owners Copyright © 2024. Naijasurenews.com - All rights reserved - info@naijasurenews.com -FOR ADVERT -Whatsapp +234 9029467326 -Owned by Gimo Internet Tech.